Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Mississippi for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Mississippi only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Mississippi (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Brett Barlow (NPI 1700240264)

Field	Value
Entity Type	Individual
Organization	Brett Barlow
Address	1220 Jefferson St
City	Laurel
State	MS
ZIP	39440
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 11, 2016

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider is functionally an outpatient oncology infusion practice: the single largest revenue driver is J9271 (pembrolizumab) with 15.4K claims producing $662.2K in revenue and representing 51.9% of the provider's Medicare receipts, and the next two top codes (Q5127 pegfilgrastim-fpgk and 99214 office E/M) further emphasize a mix of high-cost immunotherapy, supportive biologics, and evaluation/management visits that are typical for a hematology/oncology clinician. The top 3 Medicare codes account for 70.4% of this provider's total Medicare revenue, indicating that biologic infusions and related office care dominate the business model and revenue stream. The supplier profile and code mix imply a clinic built around repeated in-office infusions with associated laboratory monitoring and E/M follow-up.

Revenue concentration is high and concentrated in a few biologic administration items: J9271 alone generates $662.2K (51.9% of Medicare revenue) and Q5127 generates $157.6K (12.4%), while the precomputed top-3 share is 70.4% of total Medicare revenue. This concentration means the provider's Medicare revenue is sensitive to utilization or price changes for a small set of drugs and administration codes, and stewardship or coverage decisions affecting these products would materially affect this provider. Analysts should view this as a focused revenue base rather than a broadly diversified service mix.

Payer mix is effectively single-payer Medicare: total Medicare revenue is $1.3M and there is no Medicaid billing on file, so this clinician operates without an established Medicaid revenue stream. For contracting and network planning, treat this NPI as Medicare-dependent; Medicaid-focused strategies or state-managed care opportunities are not evident from these claims. This also implies limited exposure to state Medicaid policy shifts based on the present data.

Competitive standing by code is mixed: J9271 ranks #652 of 1841 providers nationally (64th percentile; typical, unremarkable volume), and Q5127 ranks #10 of 30 providers nationally (69th percentile; typical, unremarkable volume), indicating the provider is a modest national participant for these infusion drugs rather than a dominant player. By contrast, the 99214 office visit code ranks #16874 of 479517 providers nationally (96th percentile; notably above typical national volume), showing relatively high office visit activity per national benchmarks and suggesting a strong outpatient follow-up practice relative to peers. Overall, the provider appears regionally active with strong E/M throughput but not an outsized national leader for the principal oncology drugs.

Several ancillary and lab codes show unusually high percentile volumes consistent with an on-site infusion and diagnostic workflow: 80053 (CMP) ranks #758 of 26416 (97th percentile), 85025 (CBC) ranks #1082 of 32833 (97th percentile), and 36415 (venipuncture) ranks #1111 of 86467 (99th percentile). These high percentiles, together with frequent claims for ferritin (82728) and vitamin B12 testing (82607), indicate routine in-clinic lab monitoring tied to infusion oncology care and supportive therapies. The pattern supports the interpretation that laboratory monitoring and specimen collection are operationally important to the practice.

Statistical outlier signals are limited but notable: the office E/M code 99214 is explicitly labeled as "notably above typical" national volume and indeed sits at the 96th percentile, which may reflect a heavier-than-average follow-up or chronic-care management load for Medicare patients. Most infusion and drug administration codes are described as "typical, unremarkable volume," which aligns with their middle percentiles and suggests the provider's drug administration volumes are within expected ranges for oncology clinicians. No codes are labeled as extreme outliers in the available data.

Tenure and credentialing indicate an established practice span: the NPI was enumerated on 2016-04-11 (~10 years ago), giving roughly a decade of public Medicare billing history tied to this NPI. This tenure supports stability in the service mix observed and suggests the current pattern of infusion-centric revenue and high E/M volume has likely been in place for multiple years. For network analyses, this tenure reduces the likelihood that observed patterns are short-term anomalies.

Operational implications for payers include focused utilization review on high-cost oncology agents and related administration codes given that J9271 and Q5127 drive the bulk of Medicare revenue, while authorizations and pathway management for pembrolizumab and pegfilgrastim could have outsized impact on savings or utilization. The lack of Medicaid billing simplifies cross-payer reconciliation but also means payers seeking Medicaid-market leverage or alternate-payment arrangements will not find an existing Medicaid footprint for this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

72 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	15,400	$40	$662.2K
Q5127	Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg	590	$270	$157.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	850	$90	$78.4K
J1437	Injection, ferric derisomaltose, 10 mg	4,500	$20	$76.5K
J0897	Injection, denosumab, 1 mg	4,020	$20	$76.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	410	$90	$37.3K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	110	$330	$34.5K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,720	$10	$17.2K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	1,880	$10	$15K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	1,780	$10	$14.2K

Showing 1–10 of 72

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 72 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Mississippi Distribution

Brett Barlow — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Mississippi

Full comparison — all codes billed, vs. state median

72 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	21	10	16,700	$40	$1M
J0897	79	110	3,030	$20	$95.7K
J1454	8	10	70	$350	$24.9K
J1437	8	10	1,400	$20	$23.2K
96413	30	70	100	$80	$22.6K
99214	263	4,110	170	$70	$21.9K
J3490	8	20	90	$150	$17.8K
99232	1,933	1,490	100	$60	$12.9K
99213	2,016	4,000	100	$50	$10.3K
99215	551	900	40	$110	$9K

Showing 1–10 of 72

Related Providers

Other providers that share a Tax Identification Number (TIN) with Brett Barlow, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
South Central Regional Medical Center	MS	General Acute Care Hospital	$0	$48.1M
South Central Clinics, Inc	MS	Emergency Medicine Physician	$0	$4.5M
Wassim Mouannes	MS	Cardiovascular Disease Physician	$348K	$0
Herbert Rogers	MS	Internal Medicine Physician	$242.6K	$0
Mark Norton	MS	Internal Medicine Physician	$195.4K	$0
Bassam Mechleb	MS	Cardiovascular Disease Physician	$166.1K	$0
Amy Adams	MS	MOHS-Micrographic Surgery Physician	$152.3K	$0
William Sullivan	MS	Cardiovascular Disease Physician	$146.2K	$0
Terry Pitts	MS	Family Medicine Physician	$112.3K	$280
Monika Thoppil	MS	Internal Medicine Physician	$52.4K	$0

Nearby Providers

Other providers in the same ZIP code as Brett Barlow, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Chateau Adult Day Center, LLC	MS	In Home Supportive Care Agency	$0	$14.8M
Jones Family Medicine Clinic PLLC	MS	Primary Care Clinic/Center	$0	$9.4M
Asap Ems Corporation	MS	Land Ambulance	$850.3K	$5.4M
Magnolia Gardens Assisted Living	MS	Assisted Living Facility (Behavioral Disturbances)	$0	$5.4M
Shannon Weathers	MS	Family Nurse Practitioner	$4.6M	$0
South Central Clinics, Inc	MS	Rural Health Clinic/Center	$0	$4.4M
Tender Loving Care Homecare LLC	MS	In Home Supportive Care Agency	$0	$4.1M
Laurel Surgery & Endoscopy Center, LLC	MS	Ambulatory Surgical Clinic/Center	$520.6K	$3.4M
South Central Clinics, Inc	MS	Rural Health Clinic/Center	$0	$3.3M
South Central Regional Medical Center	MS	Ambulance	$0	$3.1M

Brett Barlow — Billing Profile & Reimbursement Data

Sign up for Brett Barlow — Billing Profile & Reimbursement Data policy alerts

Brett Barlow — Billing Profile & Reimbursement Data

Sign up for Brett Barlow — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References